What to know
When the COVID-19 pandemic began, Kenya was able to adapt foundational surveillance and laboratory platforms. CDC leveraged technical skills and trusted partnerships to build sustainable public health capacity at the national and county levels. The U.S. government donated 10 million vaccines to Kenya through the COVID-19 Vaccines Global Access (COVAX) initiative. The collaboration between CDC and the Kenyan government is instrumental to scaling up capacity to respond to serious public health threats.
![woman at vaccine location](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_008.jpg)
Photo essay
![Man talking to a lady on the computer](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_001.jpg)
![woman and man pointing on computer screen](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_002.jpg)
![people on computer monitors](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_003.jpg)
![man testing in lab](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_004.jpg)
![man and woman pointing to computer](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_005.jpg)
![Dr. Charles Mulwa, epidemiologist at the Kenya National PHEOC](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_006.jpg)
![woman typing on computer](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_007.jpg)
![woman at vaccine location](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_008.jpg)
![people having conversation](/global-health/media/images/kenya_covid19_surveillance_and_response_photo_009.jpg)